NovaBay Pharma (NBY) just unveiled an announcement.
This report includes forward-looking statements that predict the company’s strategic business plans, anticipated revenue sources, and financial outcomes based on current management expectations. These projections are speculative and come with risks and uncertainties that could significantly alter actual results. Investors are cautioned that these statements are not guarantees of future performance and are advised to refer to the company’s regulatory filings for a more detailed understanding of potential risks.
For a thorough assessment of NBY stock, go to TipRanks’ Stock Analysis page.
